MyFinsight
Home
About
Contact
rnac: the income statement
Download
Download image
Total comprehensive
loss
-$35,912K
(-48.41%↓ Y/Y)
Foreign currency
translation adjustment
-$10K
(33.33%↑ Y/Y)
Net loss
-$35,902K
(-48.46%↓ Y/Y)
Gain on change in fair
value of warrant...
-$516K
(90.90%↑ Y/Y)
Interest income
$1,548K
(-39.84%↓ Y/Y)
Grant revenue
$452K
(16.80%↑ Y/Y)
(loss) gain on change in
fair value of...
$16,900K
(11.92%↑ Y/Y)
Operating loss
-$21,066K
(-19.86%↓ Y/Y)
Total revenue
$452K
(16.80%↑ Y/Y)
Total operating
expenses
$21,518K
(19.80%↑ Y/Y)
General and
administrative
$7,716K
(17.59%↑ Y/Y)
Research and development
$13,802K
(21.07%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Cartesian Therapeutics, Inc. (RNAC)
Cartesian Therapeutics, Inc. (RNAC)